Showing results (111-120 of 976) with videos related to

Sort By:
Pageof 98
NPJ Breast Cancer|October 21, 2021
IHC-based Ki67 as response biomarker to tamoxifen in breast cancer window trials enrolling premenopausal womenStacey E P Joosten, Marius Wellenstein, Rutger Koornstra, et al.
NPJ Breast Cancer|March 23, 2022
Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumabEmanuela Ferraro, Jasmeet Singh, Sujata Patil, et al.
NPJ Breast Cancer|March 30, 2022
Gene signatures in patients with early breast cancer and relapse despite pathologic complete responseSimona Bruzas, Oleg Gluz, Nadia Harbeck, et al.
NPJ Breast Cancer|April 14, 2022
The impact of reproductive factors on DNA methylation-based telomere length in healthy breast tissueMary E Sehl, Jill E Henry, Anna Maria Storniolo, et al.
NPJ Breast Cancer|August 23, 2018
Is there a role for immunotherapy in HER2-positive breast cancer?Esther Holgado, Jose Perez-Garcia, Maria Gion, et al.
NPJ Breast Cancer|April 18, 2019
Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT-tamoxifen hybrid therapyTheodossis A Theodossiou, Muhammad Ali, Mantas Grigalavicius, et al.
NPJ Breast Cancer|October 26, 2021
Decreased enrollment in breast cancer trials by histologic subtype: does invasive lobular carcinoma resist RECIST?Mary Kathryn Abel, Michelle E Melisko, Hope S Rugo, et al.
NPJ Breast Cancer|March 5, 2022
Efficacy of platinum-based chemotherapy in metastatic breast cancer and HRD biomarkers: utility of exome sequencingLoïck Galland, Elise Ballot, Hugo Mananet, et al.
NPJ Breast Cancer|March 8, 2022
Impact of a randomized weight loss trial on breast tissue markers in breast cancer survivorsChristina M Dieli-Conwright, Maura Harrigan, Brenda Cartmel, et al.
NPJ Breast Cancer|March 1, 2022
Immunoarchitectural patterns as potential prognostic factors for invasive ductal breast cancerXue Du, Zhe Zhou, Yun Shao, et al.
Pageof 98